England is on track to be one of the first countries in the world to eliminate the hepatitis C virus (HCV), thanks to a ...

US President Donald Trump has signed an executive order that rips up the current US policy on childhood immunisations, ...

The approval makes the UK the first country in Europe to approve Foundayo (orforglipron), which becomes only the second product in the oral GLP-1 class to be cleared for use by the MHRA after Novo ...

Actio is the third acquisition for Jazz in the last few years, coming after it bought Chimerix for $935 million last year and ...

Welcome to the third edition of the pharmaphorum Clinical Trials Round-Up for 2026. May and June delivered a plethora of clinical trial updates. In the build-up to ASCO in June, our inbox was ...

Henry Gosebruch, pictured here during his time at Neumora, is replacing Paul Stoffels as CEO of Galapagos. Just a few months after announcing a plan to separate its drug and cell therapy businesses ...

Ex-BioNTech chief strategy officer Ryan Richardson is chief executive of the new outfit, which launches with $25 million in ...

The FDA has approved AbbVie's Decnupaz, a treatment for rare blood cancer blastic plasmacytoid dendritic cell neoplasm (BPDCN) that was one of the assets in its $10.1 billion takeover of ImmunoGen in ...

Dame Emma Walmsley has been CEO at GSK since 2017. This week has kicked off with the unexpected news that Emma Walmsley is standing down as chief executive of GSK after eight years, to be replaced by ...

Novo Nordisk has joined forces with Amazon Web Services (AWS) on a project that will lead to the creation of an AI ...

The Sweden-headquartered group is paying $75 million upfront to France's Innate in order to partner lacutamab, which is vying ...

The EU’s Joint Clinical Assessment (JCA), introduced 12th January 2025 under the EU Health Technology Assessment (HTA) ...